Home › Lung Cancer › North Dakota › Bismarck
Lung Cancer clinical trials in Bismarck, ND
9 studies for Lung Cancer are looking for participants at sites in and around Bismarck (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Sanford Bismarck Medical Center, Bismarck
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Sanford Bismarck Medical Center, Bismarck
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecruitingPhase 3
- Sanford Bismarck Medical Center, Bismarck
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Sanford Bismarck Medical Center, Bismarck
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- Sanford Bismarck Medical Center, Bismarck
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Sanford Bismarck Medical Center, Bismarck
Promoting Radon Testing Among Mothers of Young Children
RecruitingHealthy volunteers welcome
- University of North Dakota Center for Family Medicine, Bismarck Clinic, Bismarck
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Sanford Bismarck Medical Center, Bismarck
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Sanford Bismarck Medical Center, Bismarck
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Arlington, VA41 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Bismarck
- Non-Small Cell Lung Cancer6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Colorectal Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Melanoma3 studies
- Hypopharyngeal Cancer3 studies
- Laryngeal Cancer3 studies
- Oral Cancer3 studies
- Pancreatic Cancer3 studies
- Colon Cancer3 studies
- Rectal Cancer3 studies
- Prostate Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.